Target Name: MIR1262
NCBI ID: G100302279
Review Report on MIR1262 Target / Biomarker Content of Review Report on MIR1262 Target / Biomarker
MIR1262
Other Name(s): MIRN1262 | hsa-miR-1262 | hsa-mir-1262 | microRNA 1262 | MicroRNA 1262 | mir-1262

MIR1262: A Potential Drug Target and Biomarker

Molecular imaging has revolutionized our understanding of cancer biology, and one of the most promising targets for cancer research is the protein MIR1262. MIR1262, also known as heat shock protein 70 (HSP70), is a protein that plays a critical role in cell survival and has been implicated in a variety of cancer-related processes.

Recent studies have identified MIR1262 as a potential drug target for cancer, due to its unique structure and its involvement in various cellular processes that are often disrupted in cancer cells. MIR1262 has been shown to be highly expressed in a variety of cancer types, including breast, lung, and ovarian cancer, and has been shown to contribute to cancer cell survival, invasion, and metastasis.

In addition to its potential as a drug target, MIR1262 has also been identified as a potential biomarker for cancer. The loss of MIR1262 has been observed in various cancer types, and downregulation of MIR1262 has been shown to correlate with poor prognosis in cancer patients. This suggests that MIR1262 may serve as a valuable biomarker for cancer diagnosis and prognosis.

The identification of MIR1262 as a potential drug target and biomarker has important implications for the development of new cancer therapies. By targeting MIR1262, researchers may be able to inhibit its role in cancer cell growth and survival, leading to a reduction in cancer progression and the development of new cancer treatments.

In addition to its potential as a drug target, MIR1262 has also been shown to play an important role in the regulation of various cellular processes. MIR1262 has been shown to be involved in the regulation of cell adhesion, cell signaling, and DNA replication, among other processes.

MIR1262's role in cell regulation has also implications for its potential as a therapeutic target. By targeting MIR1262, researchers may be able to develop new treatments that specifically target its functions, rather than targeting its structure. This approach may help to avoid the development of unintended side effects associated with traditional cancer therapies.

The identification of MIR1262 as a potential drug target and biomarker also has implications for our understanding of cancer biology. MIR1262 has been shown to play a critical role in the regulation of cellular processes that are often disrupted in cancer cells, providing new insights into the mechanisms of cancer growth and progression.

In conclusion, MIR1262 is a protein that has significant implications for the development of new cancer therapies. Its unique structure and its involvement in various cellular processes make it an attractive target for drug discovery. In addition to its potential as a drug target, MIR1262 has also been identified as a potential biomarker for cancer, which has implications for its use as a diagnostic tool and for the development of personalized cancer therapies. Further research is needed to fully understand the role of MIR1262 in cancer biology and to develop new treatments that specifically target its functions.

Protein Name: MicroRNA 1262

The "MIR1262 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1262 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471